Poly(C)-binding protein 1 mediates drug resistance in colorectal cancer

Oxaliplatin (L-OHP) is standard treatment for colorectal cancer. However, resistance to L-OHP often leads to treatment failure or cancer relapse. Understanding of the mechanism underlying L-OHP resistance is important to overcome the resistance and improve colorectal cancer treatment. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiani, Zhu, Changli, Yang, Kangqun, Li, Jin, Du, Nan, Zong, Mingzhu, Zhou, Jianwei, He, Jingdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355098/
https://www.ncbi.nlm.nih.gov/pubmed/28076324
http://dx.doi.org/10.18632/oncotarget.14516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355098/
https://www.ncbi.nlm.nih.gov/pubmed/28076324
http://dx.doi.org/10.18632/oncotarget.14516

Ejemplares similares